Ikang healthcare group, inc. (KANG)
CashFlow / Yearly
Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12
Shenzhen Hospital Management
iKang Shanghai Gubei
Fujian iKang
Beijing Tianzhikangjian
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)

-16,676

-12,544

16,488

27,396

21,926

12,449

10,392

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization

42,182

37,413

30,394

19,912

10,759

7,710

6,285

Write-off of leasehold improvement

-

-

-

-

-

-

309

Share-based compensation expenses

34,822

1,941

1,949

9,153

930

2,273

216

Impairment of property and equipment

708

276

281

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-1

-163

-475

-122

Loss on liquidation of a subsidiary

-

-

-106

-

-

-

-

Gain from disposal of cost method investment

-

-

1,772

-

-

-

-

Allowance for doubtful accounts

7,317

6,136

8,509

3,758

1,100

1,800

481

Inventory written-down

-

-

-

-

-

-

25

Amortization of discount on payable purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd

-

-

-

-

-

-

155

Loss from equity method investments

-2,448

-9,547

-1,732

521

-156

-

-

Fair value change of previously held 33% equity interest of Shanghai Huajian Health Examination Management Co., Ltd

-

-

-

883

-

-

-

Changes in assets and liabilities
Accounts receivable

65,799

16,271

22,632

22,324

3,802

12,986

6,421

Inventories

1,654

3,103

1,279

698

459

97

253

Prepaid expenses and other current assets

6,344

-3,165

10,069

5,300

1,193

-176

-45

Amount due from a related party

-

-

-

-

-

477

-49

Deferred tax assets

9,925

11,476

8,296

2,147

1,232

1,081

-64

Rental deposit and other long-term assets

3,916

2,150

2,781

2,253

1,485

1,429

1,244

Accounts payable

8,629

9,337

4,766

6,115

-955

1,864

991

Accrued expenses and other current liabilities

7,453

18,741

3,979

2,123

2,884

3,071

2,235

Amount due to related parties

-

-

-

-

-

-

-198

Deferred revenues

23,165

6,846

23,914

6,546

1,774

1,589

-442

Income tax payable

2,327

4,368

702

1,129

3,824

528

1,332

Deferred government subsidy

-

-

-61

-47

-79

-62

-62

Deferred tax liabilities

-1,732

-2,183

-2,328

-863

-512

-118

-76

Net cash provided by generated from operating activities

23,005

50,043

43,602

41,097

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash generated from operating activities

-

-

-

-

34,303

16,314

14,005

Restricted cash

-408

-30,124

-20,772

36,232

18,429

-

-65

Term deposits

-4,528

-7,679

-2,361

14,621

-

-

-

Purchase of property and equipment

34,912

63,389

37,024

39,767

35,838

9,979

12,205

Proceeds from disposal of property and equipment

-

-

-

-

13

94

3

Purchase of intangible assets

-

-

157

339

-

-

-

Payments for business acquisitions (net of cash acquired of $10,165 and $6 and $516 for years ended March 31, 2016, 2017 and 2018, respectively)

1,307

2,371

37,249

56,654

41,311

6,038

2,966

Prepayment for business acquisitions

879

-

-

-

-

-

-

Payment for long-term investments

3,149

5,473

204,414

-

-

-

-

Return of prepayment for long-term investments

-

4,000

-

-

-

-

-

Proceeds from sale of cost method investment

-

-

1,897

-

-

-

-

Loan provided to related parties

-

2,508

4,719

-

4,306

-

-

Repayment of loan by related parties

140

2,324

-

1,291

3,483

-

-

Proceeds from disposal of the subsidiaries

2,231

-

-

-

-

-

-

Payment of loan receivables

-

-

1,000

740

-

-

-

Net cash used in investing activities

-34,783

-32,011

-261,533

-147,062

-

-

-

CASH FLOW FROM FINANCING ACTIVITIES
Net cash used in investing activities

-

-

-

-

-96,714

-16,058

-15,706

Proceeds from issuance of convertible redeemable preferred shares

-

-

-

-

25,181

45,000

-

Proceeds from redesignation of convertible redeemable preferred shares

-

-

-

-

669

-

-

Proceeds from redesignation of Class A common shares

-

-

-

-

612

-

-

Dividend distribution to non-controlling interest shareholder of Shanghai Guobin Medical Center Co., Ltd

-

-

-

-

-

-

428

Payments for professional fees in connection of issuance of series F convertible preferred shares

-

-

-

-

2,847

-

-

Proceeds from issuance of common shares upon initial public offering

-

-

-

135,819

-

-

-

Proceeds from issuance of common shares upon Green Shoe

-

-

-

13,399

-

-

-

Payments of initial public offering cost

-

-

-

3,574

-

-

-

Proceeds from exercise of share options

1,324

1,324

8,035

824

-

-

136

Proceeds from exercise of share option to shareholders

-

-

-

-

-

-

269

Capital contribution from non-controlling interest shareholders

909

134

567

58

732

-

-

Return of capital to non-controlling interest shareholders

572

-

-

-

-

-

-

Dividend distribution to non-controlling interest shareholders

884

704

795

-

-

-

-

Payments for business acquisitions

-

-

1,853

-

-

-

-

Proceeds from financing agreement in relation with New China Life Insurance Health Investment Management Co., Ltd

31,886

-

-

-

-

-

-

Proceeds from long-term borrowings

9,565

-

232,744

-

1,901

-

-

Payments for business acquisitions

-

-

-

1,329

3,010

-

-

Payments for assets acquisition

-

-

-

32

-

-

-

Proceeds from short-term borrowings

65,679

37,176

54,126

59,404

20,298

7,800

1,563

Proceeds from convertible loan

-

-

-

-

-

2,000

-

Repayment of convertible loan

-

-

-

-

2,000

-

-

Repayments of short-term borrowings

103,403

60,610

55,359

20,860

7,383

3,976

-

Repayments of long-term borrowings

-

29,741

-

1,869

-

-

-

Net cash provided by (used in) financing activities

4,504

-52,421

237,465

173,570

-

-

-

Effect of exchange rate on cash and cash equivalents

5,277

-8,824

-8,759

-490

-

-

-

Net cash provided by financing activities

-

-

-

-

29,342

50,824

-1,161

Effect of exchange rate on cash and cash equivalent

-

-

-

-

136

199

595

Net increase (decrease) in cash and cash equivalents

-1,997

-43,213

10,775

67,115

-32,933

51,279

-2,267

Supplemental cash flow information
Income tax paid

17,894

11,649

13,327

13,678

-

-

-

Interest paid

24,673

3,600

1,957

2,392

-

-

-

Income tax paid

-

-

-

-

8,224

6,850

2,756

Interest paid

-

-

-

-

1,068

308

-

Supplemental non-cash financing and investing activities
Payable for purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd.

-

-

-

-

8,049

12,379

-11,572

Payable for business acquisitions

-10,127

-6,436

-9,350

11,795

3,628

505

-1,383

Payable for purchase of long term investments

-

-

3,743

-

-

-

-

Payable for assets acquisitions

-

-

-

-

-

32

-

Payable for purchase of property and equipment

12,456

11,830

7,109

7,902

8,568

3,645

1,022

Prepayment for business acquisitions

4,524

3,322

10,570

22,215

1,705

-

-

Prepayment for long term investments

-

-

4,000

-

-

-

-

Prepayment for purchase of property and equipment

17,699

12,677

11,318

5,435

7,312

-

-

Capital contribution, through other assets, relating to non-controlling interest

461

-

-

-

-

-

-